Zhongshan People's Hospital
In research, Zhongshan People's Hospital stands highest in Medicine (#2,005 of 10,443 worldwide), Health Sciences (#2,617 of 11,982 worldwide) and Life Sciences (#3,405 of 7,800 worldwide), 2022–2025. Relative to its size it is most specialised in Pulmonary and Respiratory Medicine — Pulmonary and Respiratory Medicine is 5.9× its share of world research.
- World rank, 2022–2025
- #6,848 of 28,054 · #13,144 all time
- Rank in China
- #1,409 of 3,058
- Research works
- 1.7k ▼ 41% vs 2013–17
- Citations
- 7.5k 4.3 per fractional work
- Top-10% rate
- 18.0% record average 16.5%
- Open access
- 35% world 28%
What is Zhongshan People's Hospital known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #2,005 of 10,443 | 17.1% | 314 | #3488 | |
| Health SciencesDomain | #2,617 of 11,982 | 17.4% | 333 | #4553 | |
| Life SciencesDomain | #3,405 of 7,800 | 18.0% | 112 | #7536 | |
| Biochemistry, Genetics and Molecular BiologyField | #3,060 of 3,579 | 15.6% | 75 | #6756 |
Each strip is that field’s whole ranked pool, with the notch where Zhongshan People's Hospital sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Which of those standings moved
The same fields on both windows: where it stood over the whole record, and where it stands in 2022–2025. The distance is the story, and it is the one thing the two rank columns above cannot show.
- Medicine#3,488 #2,005
- Health Sciences#4,553 #2,617
- Life Sciences#7,536 #3,405
- Biochemistry, Genetics and Molecular Biology#6,756 #3,060
A dot further right is a better standing. Fields it was not ranked in over the whole record are left out.
What does Zhongshan People's Hospital specialise in?
Where its research is concentrated relative to its size: Pulmonary and Respiratory Medicine takes 5.9× the share of its output that it takes of world research.
- Pulmonary and Respiratory MedicineSubfield · 44.8 works5.9×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 4.0×. Every wedge is a field page.
- Immunology and Microbiology 4.0×
- Medicine 3.3×
- Biochemistry, Genetics and Molecular Biology 2.9×
- Pharmacology, Toxicology and Pharmaceutics 2.1×
- Dentistry 1.5×
- Nursing 1.4×
- Neuroscience 1.3×
- Health Professions 0.9×
- Psychology 0.7×
- Veterinary 0.7×
- Chemistry 0.4×
- Materials Science 0.2×
- Engineering 0.2×
- Environmental Science 0.2×
- Agricultural and Biological Sciences 0.1×
- Chemical Engineering 0.1×
- Mathematics 0.1×
- Decision Sciences 0.1×
- Computer Science 0.1×
- Physics and Astronomy 0.1×
- Energy 0.1×
- Social Sciences 0.1×
- Business, Management and Accounting 0.0×
- Economics, Econometrics and Finance 0.0×
Who are the top researchers at Zhongshan People's Hospital?
Ranked on the composite score, Ju Tian lead among researchers whose main affiliation is Zhongshan People's Hospital.
- 1 Ju Tian China · #1,150,853 worldwide 25 citations · 15 works
Which keywords describe research at Zhongshan People's Hospital?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Cancer, Inflammation, Epidemiology, Chemotherapy, Tumor Microenvironment, Treatment, Diagnosis and Oxidative Stress.
- Long Noncoding RNAs
- Adjuvant Therapy
- GPX4
- Lipid Peroxidation
- Cancer Progression
- Epigenetic Regulation
- Neoadjuvant Therapy
- Survival
- Clinical Trials
- Surgical Management
- Cardiovascular Disease
- Metastasis
- Prognostic Factors
- Quality of Life
- Biomarkers
- Metabolic Syndrome
- Tumor Microenvironment
- Treatment
- Oxidative Stress
- Inflammation
- Epidemiology
- Cancer
- Chemotherapy
- Diagnosis
- Management
- Immunotherapy
- Gene Expression
- Clinical Practice Guidelines
- Radiotherapy
- Risk Factors
- Immunity
- Thrombosis
- Cell Death
- Heart Failure
- Hepatocellular Carcinoma
- Targeted Therapy
- Biogenesis
- Ferroptosis
- Cell Differentiation
- Prognostic Markers
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology50▲ 2.6×95 topics
- Inflammation42▲ 4.1×72 topics
- Cancer36▲ 5.5×43 topics
- Oxidative Stress24▲ 3.0×44 topics
- Chemotherapy24▲ 7.1×22 topics
- Treatment23▲ 3.8×37 topics
- Diagnosis21▲ 4.5×33 topics
- Tumor Microenvironment20▲ 9.0×8 topics
- Management18▲ 4.7×23 topics
- Metabolic Syndrome18▲ 4.4×22 topics
- Immunotherapy16▲ 4.6×17 topics
- Biomarkers16▲ 4.8×15 topics
- Gene Expression16▲ 5.4×11 topics
- Quality of Life15▲ 2.1×33 topics
- Clinical Practice Guidelines15▲ 5.6×14 topics
- Prognostic Factors15▲ 7.0×14 topics
- Radiotherapy15▲ 7.9×10 topics
- Metastasis14▲ 8.7×12 topics
- Risk Factors14▲ 2.7×27 topics
- Cardiovascular Disease14▲ 2.5×28 topics
- Immunity12▲ 6.1×10 topics
- Surgical Management12▲ 6.0×15 topics
- Thrombosis12▲ 8.6×7 topics
- Clinical Trials10▲ 3.2×16 topics
- Cell Death10▲ 8.5×6 topics
- Survival10▲ 15×4 topics
- Heart Failure10▲ 4.5×11 topics
- Neoadjuvant Therapy9▲ 7.7×5 topics
- Hepatocellular Carcinoma8▲ 7.9×4 topics
- Epigenetic Regulation8▲ 7.5×4 topics
- Targeted Therapy8▲ 7.0×5 topics
- Cancer Progression8▲ 8.4×7 topics
- Biogenesis7▲ 8.4×3 topics
- Lipid Peroxidation7▲ 13×3 topics
- Ferroptosis7▲ 18×1 topic
- GPX47▲ 18×1 topic
- Cell Differentiation6▲ 14×2 topics
- Adjuvant Therapy6▲ 9.6×2 topics
- Prognostic Markers6▲ 12×3 topics
- Long Noncoding RNAs6▲ 14×1 topic
Which research topics does Zhongshan People's Hospital publish most on?
By volume in 2022–2025: Ferroptosis and cancer prognosis, Cancer-related molecular mechanisms research, Lung Cancer Diagnosis and Treatment and Hepatocellular Carcinoma Treatment and Prognosis.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Ferroptosis and cancer prognosis Pulmonary and Respiratory Medicine 7 works
- 2 Cancer-related molecular mechanisms research Cancer Research 6 works
- 3 Lung Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 5 works
- 4 Hepatocellular Carcinoma Treatment and Prognosis Hepatology 5 works
- 5 Mechanical Circulatory Support Devices Biomedical Engineering 5 works
- 6 Cancer Immunotherapy and Biomarkers Oncology 4 works
- 7 Head and Neck Cancer Studies Otorhinolaryngology 4 works
- 8 Inflammatory Biomarkers in Disease Prognosis Oncology 4 works
- 9 RNA modifications and cancer Molecular Biology 4 works
- 10 Epigenetics and DNA Methylation Molecular Biology 3 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Zhongshan People's Hospital's research output changed?
Output in 2018–2022 was 41% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Zhongshancun
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.